DUSSELDORF, Germany, May 3, 2023 /PRNewswire/ LenioBio GmbH, the Düsseldorf-based cell-free protein expression company, has announced that its founder and CEO, Dr. Remberto Martis, will be
DÜSSELDORF, Germany, June 8, 2022 /PRNewswire/ LenioBio GmbH today announced it had achieved a key milestone for the company with the successful linear scaling of its cell-free protein synthesis
DUSSELDORF, Germany, May 16, 2022 /PRNewswire/ the German life science biotech firm, LenioBio GmbH, today announced the generation of a novel plant glycan knockout cell line that will increase
DUSSELDORF, Germany, May 9, 2022 /PRNewswire/ LenioBio GmbH announced today that the company has been awarded a 2.75M Euro Eurostars grant to lead a consortium comprising one academic and